Semaglutide, a GLP-1 receptor agonist marketed as Ozempic for type 2 diabetes and Wegovy for chronic weight management, does not damage or permanently impair metabolic function
Compounded semaglutide at $199/month provides the best combination of effectiveness and affordability, producing 10-15% average weight loss at 85% less cost than brand-name Wegovy ($1,349/month)
Poly ADP-ribose polymerase-1 inhibition by 3-aminobenzamide recuperates HEI-OC1 auditory hair cells from blast overpressure-induced cell death
In this clinical trial study, oral liposomal glutathione supplementation (L-GSH) or placebo was given to individuals with T2DM to investigate the therapeutic effects of L-GSH supplementation
Some protocols use split dosing to create multiple pulses
100 mg/kg cinchonine significantly improved liver function by reducing the ALT, ALP and LDH levels